Search:

Biotechnology Headlines from PR Newswire


< Go Back

Glide Pharma Completes Successful Proof-of-Concept Study with Novel Solid Dose Formulation of Octreotide
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 24
EHE International Certifies Dignity Health Medical Group Nevada, LLC as Its Newest Partner
ADB International Group Inc. Announces Partnership with Austen BioInnovation Institute to Bring E-QURE BST™ Wound Healing Device to U.S. Market
Cynthia Fleck to Lead Marketing and Clinical Resource Development for Viniferamine® Medical Skin and Wound Care Products
Biosimilars/Follow-on-Biologics Market is Expected to Reach $35 Billion, Globally, by 2020
Local Southern California Medical Technology Event Draws Big Name Speakers
Louisiana Organ Procurement Agency Leveraging CompuMed to Secure More Donor Hearts
Global Graphene Manufacturing Leader, Graphene Frontiers, Receives Series Seed B Funding To Assure Production Of The Next Generation Of Biological And Chemical Sensor Technology
Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder
Galmed Pharmaceuticals Second Quarter 2014 Conference Call and Webcast Scheduled for Friday, July 25, 2014
Maxwell Biotech Venture Fund's Portfolio Company MetaMax Announces Enrollment of First Patients in Phase 1/2a Clinical Trial of its Lead Anticancer Drug MM-D37K
Milestone Pharmaceuticals Appoints Chief Medical Officer Portuguese English English
Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A
Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome
Dipexium Pharmaceuticals Initiates Second of Two Pivotal Phase 3 Clinical Trials of Locilex® in Patients with Mild Infections of Diabetic Foot Ulcers
Celsion Corporation Announces $1 Million NIH, NIBIB - Career Development Award Grant for Glioblastoma Research with ThermoDox® and HIFU
Braeburn Pharmaceuticals Enrolls First Patients In Late-Stage Clinical Study Of Probuphine® For Opioid Dependence
Can-Fite CEO to Deliver Scientific Presentation and Serve on Expert Panel at Purines 2014 in Bonn, Germany on July 23-27, 2014
Sequenom Laboratories Expands International Noninvasive Prenatal Testing Services To Broader Population With VisibiliT™ Test
Synthetic Biologics' Academic Collaborator to Present Novel Monoclonal Antibody Combination for Treating Whooping Cough (Pertussis) at Gordon Research Conference
Global Next Generation Biometric Market by Technology, Function, Application & by Geography - Forecasts & Analysis to 2020
CTI BioPharma Expands Access To PIXUVRI® With Approval In Israel And Add-on Reimbursement Status In The Netherlands English
Optimizing Market Research to Best Serve Internal Customers
Neogen COO resigns
Regeneron to Report Second Quarter 2014 Financial and Operating Results and Host Conference Call and Webcast on August 5, 2014
Neurotrope Board of Directors Appoints Chairmen Ramat and Freiman as Interim Co-CEOs
Contract Research Organization Welcomes Dr. Lani Clark as Head, Dermatology Clinical Research
Daktari Accepted into WHO Prequalification of Diagnostics Programme
WaferGen Bio-Systems Announces Appointment of Ivan Trifunovich as Chairman of the Board; Joel Kanter to Serve as Lead Independent Director
Valeant Pharmaceuticals Files Investor Presentation
Genetic Blueprint of Bread Wheat Genome Unveiled
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
Part I. Not for release, publication or distribution, in whole or in part, directly or indirectly, in, into or from any jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction. English
Two-Year Results From Phase 3 VIVID-DME Trial of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema Show Sustained Improvement in Vision
Young Moscovite Researcher Receives this Year's "Basel Declaration Award for Education in Animal Research"
Vanda Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 7, 2014
SURPASS Announces Two Strategic Hires in Silicon Valley Facility and Launch of Social Media Accounts
Prana Alzheimer's disease Development Program update
Cepheid Reports 2014 Second Quarter Results
Amgen Announces Positive Phase 3 Results for AMG 416 for the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease Receiving Hemodialysis
Exelixis, Inc., Analyst Report; The Upside Potential is Worth the Risk by BrokerBank Securities, Inc.
aTyr, The Hong Kong University of Science and Technology, The Scripps Research Institute and Stanford University Join in the Discovery of a New Class of Human Proteins
First Comprehensive Library of Master Genetic Switches in Plants
Jump Start: New Program Aims at Getting Severely Obese Children Treated More Quickly
Global and Chinese Sodium Borohydride Industry Report 2014
BiologicTx® Selected As The Specialty Pharmacy For Prospective, Global, Multi-Center, Observational Treatment Registry Study Of Intravenous Immunoglobulin Maintenance Therapy In Alloantibody Positive Renal Allograft Recipients
Simbionix's Innovative Solution for Patient Specific Simulation Receives Further Global Recognition
Health Enhancement Products, Inc. Secures Capital Increase To Fund Ongoing Bovine And Canine Studies For Licensing Opportunities

< Prev Next >
PR Newswire - United Business Media